Abstract

New Drug Update

Author(s): Peter F. Buckley, MD

Neurocrine Biosciences, Inc. has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for once-daily dosing of valbenazine

• PDF